TP53 and neoplasm: Advances in our understanding of the mechanisms which canonically regulate p53 stability and function have facilitated the development of numerous small molecules and drugs that exploit vulnerabilities within the p53 regulatory network in tumours retaining wild-type protein expression [14,215].